share_log

Cantor Fitzgerald Reiterates Overweight on Aravive, Maintains $18 Price Target

Cantor Fitzgerald Reiterates Overweight on Aravive, Maintains $18 Price Target

坎托·菲茨杰拉德重申增持Aravive,维持18美元的目标股价
Benzinga ·  2023/07/17 09:50

Cantor Fitzgerald analyst Louise Chen reiterates Aravive (NASDAQ:ARAV) with a Overweight and maintains $18 price target.

Cantor Fitzgerald分析师Louise Chen重申Aravive(纳斯达克:ARIV)增持,并维持18美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发